GTS Securities’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2.93M Sell
11,972
-21,808
-65% -$5.08M 0.1% 133
2025
Q4
$6.99M Buy
33,780
+22,300
+194% +$4.41M 0.24% 59
2025
Q3
$2.13M Buy
11,480
+3,388
+42% +$580K 0.08% 192
2025
Q2
$1.24M Sell
8,092
-3,856
-32% -$593K 0.06% 286
2025
Q1
$1.98M Sell
11,948
-2,572
-18% -$402K 0.09% 177
2024
Q4
$2.1M Buy
14,520
+11
+0.1% +$1.71K 0.1% 153
2024
Q3
$2.35M Sell
14,509
-32,935
-69% -$5.25M 0.01% 1458
2024
Q2
$6.93M Buy
47,444
+43,912
+1,243% +$6.53M 0.01% 671
2024
Q1
$559K Sell
3,532
-57,647
-94% -$9.18M ﹤0.01% 2493
2023
Q4
$9.59M Sell
61,179
-25,049
-29% -$3.84M 0.02% 628
2023
Q3
$13.4M Sell
86,228
-60,712
-41% -$10M 0.02% 469
2023
Q2
$24.3M Buy
+146,940
New +$23.7M 0.77% 28

Other funds holding JNJ

GTS Securities's JNJ Position: Q1 2026 in Review

GTS Securities reduced its Johnson & Johnson (JNJ) stake by 65% in Q1 2026, selling an estimated $5.08M and leaving 11,972 shares worth $2.93M. The position accounts for 0.1% of the portfolio, ranked #133.

GTS Securities first reported a position in JNJ in Q2 2023 and has held it in 12 quarters since. The position peaked at $24.3M in Q2 2023. 4,618 funds tracked by Wall St. Rank hold JNJ as of Q1 2026.

  • GTS Securities held 11,972 shares of Johnson & Johnson worth $2.93M as of Q1 2026.
  • GTS Securities sold 21,808 Johnson & Johnson shares in Q1 2026, an estimated $5.08M.
  • Johnson & Johnson made up 0.1% of GTS Securities's portfolio in Q1 2026, its #133 holding.
  • GTS Securities first reported a position in Johnson & Johnson in Q2 2023 and has held it in 12 quarters since.
  • GTS Securities's Johnson & Johnson position peaked at $24.3M in Q2 2023.
  • 4,618 funds tracked by Wall St. Rank held Johnson & Johnson as of Q1 2026.

Based on GTS Securities's 13F filing for Q1 2026, filed 15 May 2026.